Kytos Pharmaceuticals Pty Ltd

Regulatory activities for this sponsor.

6 result(s) found, displaying 1 to 6

Choletos Cancelled under Section 30(1)(c) of the Act

19 April 2022

Cancellation by sponsor

Requested by Kytos Pharmaceuticals Pty Ltd
MenoRhythm Cancelled under Section 30(1)(c) of the Act

19 April 2022

Cancellation by sponsor

Requested by Kytos Pharmaceuticals Pty Ltd
Choletos (Kytos Pharmaceuticals Pty Ltd)

8 June 2021

Listed medicine compliance report

Medicine continues to be permitted for supply (View full entry for advice on the safety of using this medicine.)
Brio-Prost Cancelled under Section 30(1)(c) of the Act

13 June 2019

Cancellation by sponsor

Requested by Kytos Pharmaceuticals Pty Ltd
Choletos Cancelled under s30(1)(c)

16 February 2017

Cancellation by sponsor

Requested by Kytos Pharmaceuticals Pty Ltd
Brio-Prost Cancelled under s30(1)(c)

16 February 2017

Cancellation by sponsor

Requested by Kytos Pharmaceuticals Pty Ltd